Document ID: chunk:federal_register_of_legislation:F2025L00215:schedule:1:p51
Version: federal_register_of_legislation:F2025L00215
Segment Type: schedule
Provision Reference: sch 1 (pt 51/51)
Character Range: 190996–193362

in the column headed "Brand" after entry for the Brand "METEX XR": Metformin Sandoz XR
[142] Schedule 5, entry for Metformin [GRP-24200]
substitute:
Metformin  GRP-24200  Tablet (extended release) containing metformin hydrochloride 500 mg  Oral  APO-Metformin XR 500
                                                                                                 Diabex XR 500
                                                                                                 Diaformin Alphapharm XR
                                                                                                 Metex XR
                                                                                                 Metformin Sandoz XR
                                                                                                 METFORMIN-WGR XR
                                                                                                 Pharmacor Metformin XR

[143] Schedule 5, entry for Modafinil
omit from the column headed "Brand": Modafinil Mylan
[144] Schedule 5, entry for Olanzapine in the form Tablet 10 mg (orally disintegrating) [GRP-15723]
omit from the column headed "Brand": Olanzapine ODT generichealth 10
[145] Schedule 5, entry for Pregabalin [GRP-21640]
omit from the column headed "Brand": Cipla Pregabalin
[146] Schedule 5, entry for Quetiapine [GRP-19767]
omit from the column headed "Brand": Quetiapine APOTEX
[147] Schedule 5, omit entry for Quinapril
[148] Schedule 5, entry for Ramipril in the form Tablet 5 mg [GRP-15424]
omit from the column headed "Brand": Tryzan Tabs 5
[149] Schedule 5, entry for Ramipril in the form Tablet 10 mg [GRP-15431]
omit from the column headed "Brand": Tryzan Tabs 10
[150] Schedule 5, entry for Ramipril in the form Tablet 1.25 mg [GRP-15640]
omit from the column headed "Brand": Tryzan Tabs 1.25
[151] Schedule 5, entry for Ramipril in the form Tablet 2.5 mg [GRP-15769]
omit from the column headed "Brand": Tryzan Tabs 2.5
[152] Schedule 5, entries for Timolol
omit:
Timolol  GRP-28880  Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL (S19A)  Application to the eye  Timoptol XE 0.50% (South Africa)

[153] Schedule 5, after entry for Ursodeoxycholic acid
insert:
Ursodeoxycholic acid  GRP-29488  Capsule 500 mg  Oral  Ursodox GH
Ursodeoxycholic acid  GRP-29488  Tablet 500 mg   Oral  Ursofalk